non-glp-1 medications GLP-1 nausea: How to handle GLP-1s' most common side effect What is the pipeline for

What clinical evidence supports GLP-1 use in hidradenitis suppurativa

The "maintained improvements" group (approximately 30-40% of users) reports substantial benefit retention 6-12 months post-discontinuation, typically characterized by users who completed 6+ month treatment courses using adequate concentrations (1-2% GHK-Cu), maintained consistent application patterns, addressed underlying skin damage during treatment allowing structural improvements, optimized complementary skincare including sun protection and moisturization, maintained healthy lifestyle supporting collagen synthesis including adequate protein intake and sleep, and possessed favorable genetics for collagen production and skin aging resistance

Alonso-Roman R, Last A, Mirhakkak MH, Sprague JL, Mller L, Gromann P, et al

The center of the rosettes sometimes contains amphophilic material or small, endothelium-lined vessel